Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis
Clinical Rheumatology, 05/09/08
Laas K et al. - Etanercept can be suggested in RA patients when infliximab has failed or discontinued for other reasons.
Methods- Disease activity was measured in RA pts (n=49) after switching from infliximab to etanercept
- Reasons for infliximab discontinuation were: 42% for failure to respond by >ACR 50% criteria; 12% for AEs; 46% for non-medical reasons
- Clinical outcome after the switch was compared between the groups according to the reason of infliximab discontinuation
- Disease activity was measured with DAS28
- In pts in the non-medical reasons group, the disease activity was suppressed effectively both during infliximab and etanercept
- One-year drug survival of etanercept in this group was the highest of 77% among the 3 groups
- In pts in the infliximab failure and AE groups, DAS28 values improved during etanercept therapy
- The 1-yr drug survival of etanercept was 43% and 50% respectively
- For RA pts who discontinued taking infliximab because of non-medical reasons experienced similar treatment efficacy during both biological agents
- The treatment with etanercept provided sufficient disease control also for pts with infliximab failure or AE
Related Articles
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 71%
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09
Relevance Score: 70%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09
Relevance Score: 69%
Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 69%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Divalproex Sodium-Induced Eosinophilic Pleural Effusion
American Journal of Therapeutics, 12/04/09
Lithium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/04/09
Acute Generalized Exanthematous Pustulosis: A Rare Clinical Entity With Use of Piperacillin/Tazobactam
American Journal of Therapeutics, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


